Profil
Filip Borgions currently works at argenx SE, as Chief Technology Innovation Officer.
Dr. Borgions also formerly worked at Thrombogenics, Inc., as Principal.
Dr. Borgions received his undergraduate degree and doctorate degree from Katholieke Universiteit Leuven.
Aktiva positioner av Filip Borgions
| Företag | Position | Start |
|---|---|---|
| ARGENX SE | Teknisk/Vetenskaplig/F&U Direktör | 2015-01-01 |
Tidigare kända positioner av Filip Borgions
| Företag | Position | Slut |
|---|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Företagsledare/Principal | - |
Filip Borgionss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
















